The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease - ScienceDirect

Combined alcoholic and non-alcoholic steatohepatitis - ScienceDirect

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes - ScienceDirect

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies - ScienceDirect

PDF) Loss of hepatic Mboat7 leads to liver fibrosis

Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease - ScienceDirect

Nonalcoholic fatty liver disease stratification by liver lipidomics - ScienceDirect

Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease

High-density lipoproteins and non-alcoholic fatty liver disease - ScienceDirect

A metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes

Hepatic deletion of Mboat7 (LPIAT1) causes activation of SREBP-1c and fatty liver - ScienceDirect

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans - ScienceDirect

Established and emerging factors affecting the progression of nonalcoholic fatty liver disease - ScienceDirect